NEW YORK – Interpace Biosciences reported after the close of the market on Thursday that its first quarter revenues rose 53 percent year over year.
For the three months ended March 31, the Parsippany, New Jersey-based firm reported revenues of $9.2 million, up from $6.0 million in the year-ago quarter and beating the consensus Wall Street estimate of $8.9 million.